LCN2 is involved in the development of a variety of diseases: non-neoplastic diseases (such as cachexia, pneumonia, and kidney disease36,37) as well as malignant tumors (such as hepatocellular carcinoma and pancreatic cancer27,38). This evidence concerns the gene LCN2 and susceptibility to pneumonia measurement.